Data as of Jul 22
| -0.71 / -0.41%|
The 16 analysts offering 12-month price forecasts for Allergan Inc have a median target of 197.50, with a high estimate of 240.00 and a low estimate of 130.00. The median estimate represents a +15.88% increase from the last price of 170.43.
The current consensus among 20 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.